Literature DB >> 6721920

Peptide-induced emesis in dogs.

D O Carpenter, D B Briggs, N Strominger.   

Abstract

Systemic administration of apomorphine, angiotensin II, neurotensin and leucine-enkephalin induces emesis in dogs in a dose-dependent fashion. Receptors for Leu-enkephalin and angiotensin II but not apomorphine show receptor desensitization, such that a second systemic administration 5 min after the first is ineffective. Domperidone blocked the emetic response to apomorphine but not to Leu-enkephalin or angiotensin II. Naloxone selectively blocked the Leu-enkephalin response, while saralasin blocked responses to both angiotensin II and Leu-enkephalin, but not apomorphine. Chlorpromazine prevented the emetic response to all agents, suggesting a dopamine receptor in the emetic pathway on the brain side of the blood-brain barrier. In dogs with ablation of the area postrema the emetic response to apomorphine and all peptides was prevented.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6721920     DOI: 10.1016/0166-4328(84)90220-1

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  12 in total

Review 1.  Potential of substance P antagonists as antiemetics.

Authors:  P Diemunsch; L Grélot
Journal:  Drugs       Date:  2000-09       Impact factor: 9.546

2.  The anti-emetic effects of CP-99,994 in the ferret and the dog: role of the NK1 receptor.

Authors:  J W Watson; S F Gonsalves; A A Fossa; S McLean; T Seeger; S Obach; P L Andrews
Journal:  Br J Pharmacol       Date:  1995-05       Impact factor: 8.739

Review 3.  Do conditioned taste aversions result from activation of emetic mechanisms?

Authors:  V L Grant
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

4.  Use of granisetron transdermal system in the prevention of chemotherapy-induced nausea and vomiting: a review.

Authors:  Albert Tuca
Journal:  Cancer Manag Res       Date:  2009-12-16       Impact factor: 3.989

Review 5.  A History of Drug Discovery for Treatment of Nausea and Vomiting and the Implications for Future Research.

Authors:  Gareth J Sanger; Paul L R Andrews
Journal:  Front Pharmacol       Date:  2018-09-04       Impact factor: 5.810

Review 6.  Neurokinin-1 Antagonists for Postoperative Nausea and Vomiting.

Authors:  Zhaosheng Jin; Neil Daksla; Tong J Gan
Journal:  Drugs       Date:  2021-06-09       Impact factor: 9.546

Review 7.  Mechanisms of Nausea and Vomiting: Current Knowledge and Recent Advances in Intracellular Emetic Signaling Systems.

Authors:  Weixia Zhong; Omar Shahbaz; Garrett Teskey; Abrianna Beever; Nala Kachour; Vishwanath Venketaraman; Nissar A Darmani
Journal:  Int J Mol Sci       Date:  2021-05-28       Impact factor: 5.923

8.  Recent advances in pharmacotherapy of chemotherapy-induced nausea and vomiting.

Authors:  Prasan R Bhandari
Journal:  J Adv Pharm Technol Res       Date:  2012-10

9.  Casopitant: a novel NK(1)-receptor antagonist in the prevention of chemotherapy-induced nausea and vomiting.

Authors:  Christina Ruhlmann; Jørn Herrstedt
Journal:  Ther Clin Risk Manag       Date:  2009-05-20       Impact factor: 2.423

10.  Postoperative nausea and vomiting: The achilles heel of anesthesiologists.

Authors:  Shuchita Garg; Sudhakar Subramani; Harsh Sachdeva
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2017 Oct-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.